Health · 3 views
Chemo-Free First-Line Treatment Yields Huge PFS Gain in dMMR Endometrial Cancer
(MedPage Today) -- Single-agent immunotherapy as first-line treatment led to a huge improvement in progression-free survival (PFS) in inoperable recurrent/advanced mismatch repair-deficient (dMMR) endometrial cancer, a large randomized…
Summary
(MedPage Today) -- Single-agent immunotherapy as first-line treatment led to a huge improvement in progression-free survival (PFS) in inoperable recurrent/advanced mismatch repair-deficient (dMMR) endometrial cancer, a large randomized trial showed
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedCoverage Context
More from Health
Continue reading recent Health coverage
- 5 calisthenics moves for a full-body workout you can do anywhereContinue reading
- STI screening linked to fewer preterm birthsContinue reading
- Vitamin-carrying protein pathway shows promise for brain drug deliveryContinue reading
- QuickStats: Percentage of Children and Adolescents Aged 5-17 Years Who Had Ever Received a Diagnosis of Attention-Deficit/Hyperactivity Disorder, by Sex and Ye…Continue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow